Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€76.62

€76.62

4.570%
3.32
4.570%
€120.85

€120.85

 
10.08.26 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Latest predictions
€86.68
05.08.26
18.46%
buy
€91.94
03.08.26
8.68%
buy
22.07.26
21.27%
buy
€105.23
01.07.26
27.70%
buy
€108.79
30.06.26
31.69%
buy
19.05.26
32.70%
buy
Your prediction

Transmedics Group Inc Stock

A very strong showing by Transmedics Group Inc today, with an increase of €3.32 (4.570%) compared to yesterday's price.
Transmedics Group Inc is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
As a result the target price of 120 € shows a very positive potential of 56.62% compared to the current price of 76.62 € for Transmedics Group Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Transmedics Group Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 18.46%
Target price 86.680
Change
Ends at 05.08.27

TransMedics Group (TMDX) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $100.00 price target on the stock, down from $120.00.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 8.68%
Target price 91.944
Change
Ends at 03.08.27

TransMedics Group (TMDX) had its price target lowered by Needham & Company LLC from $142.00 to $106.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

TransMedics Group (TMDX) had its "overweight" rating reaffirmed by Piper Sandler.
Ratings data for TMDX provided by MarketBeat
Show more